Coral Gables Research Articles

Simultaneous bilateral rupture of the pectoralis major tendons while exercising on the rings

UHZ Sports Medicine Institute, Coral Gables, FL Disclosures: The authors have no disclosures related to this work. Correspondence to: Gary M. Kiebzak, PhD, UHZ Sports Medicine Institute, 1150 Campo Sano Avenue, Suite 200, Coral Gables, Florida 33146 Tel: +786 268 6228; fax: +786 268 6280; e-mail: [email protected]

DVD Review

The Balance Evaluation Systems Test (BESTest)1 is a recently developed clinical assessment tool to identify the postural control systems responsible for deficits in functional balance. Six postural control systems (biomechanical constraints, stability limits/verticality, postural transitions, reactive postural responses, sensory orientation, and dynamic stability during gait) are examined. Each system examined has several associated test items based on both novel and known balance measures. Items are scored using a 4-point ordinal scale with 0 being the lowest score and 3 being the highest score. Percentage scores are computed and reported for each system and for the total assessment. The purpose of the BESTest training DVD is to assist clinicians in learning proper administration and scoring of this new assessment tool. The DVD is available for purchase from through the technology transfer web site of the Oregon Health & Sciences University at http://www.ohsu.edu/tech-transfer/portal/technology.php?technology_id=217191 . The training DVD is easy to load and navigate, and can be used on either PC or Mac platforms. Once loaded, the main menu screen contains icons for playing an introduction video clip, printing a copy of the BESTest, reviewing acknowledgments from the authors, and beginning the interactive tutorial for administering and scoring the test. At any time, the user can jump to a specific section or test, get help using the icons, or quit the tutorial. A video clip introduction on the theoretical background and use of the BESTest and the training DVD is provided by Dr. Fay Horak, developer of the BESTest. The interactive tutorial consists of 3 sets of video instructions: examiner, patient, and scoring. The video clips embedded in the tutorial provide a visual demonstration of an examiner performing each item with a patient. The examiner section provides an audiovisual demonstration on how to safely and consistently administer each item. Emphasis in this section is placed on examiner and patient positioning, how the test is performed, and what equipment is required to complete the test item. The patient section provides audiovisual instructions for the examiner to give to the patient for each of the test items. Emphasis is placed on verbal instructions given by the examiner. The scoring criteria section provides written descriptions of how to discriminate performance using the 0- to 3-point scoring scale. Video clips demonstrating performance for a given score can be accessed simply by clicking on the icon related to that score. Written descriptions and video clips can be viewed concurrently. This training video and downloadable written material provide a comprehensive learning experience for the clinician, researcher, or student. Directions for administration and scoring are straightforward and the video clips provide a good vantage point for the examiner to discriminate between the 0 and 3 scoring criteria. It is best to download and print a copy of the BESTest from the main menu, while reviewing the training video. These materials include a list of equipment required, administration instructions, and scoring sheets. The BESTest has reported an intraclass correlation coefficient for interrater reliability of 0.91 for the entire test with a range from 0.79 to 0.96 for the subtests in adults with balance deficits.1 Use of this training DVD should enhance examiner proficiency and reliability in administration and scoring of the tool. James Moore, PT, PhD, NCS Assistant Professor Department of Physical Therapy University of Miami Miller School of Medicine Coral Gables, Florida

Co-editors’ Messages

1. Bernard Nusbaum, MD (drnusbaum{at}yahoo.com) 1. Coral Gables, Florida </br>![][1]</img> If you attended the Boston meeting, you realized that the science of our specialty continues to move forward at a steady pace. Presentations on, for example, laser therapy, growth factors, and

Co-editors’ Messages

1. Bernard Nusbaum, MD (drnusbaum{at}yahoo.com) 1. Coral Gables, Florida </br>![][1]</img> The ISHRS is synonymous with education, networking, and the industry of hair restoration, but the Society would not exist without people like Cheryl Pomerantz, RN whose recent passing we mourn, and

ZoologyDo Bats Drink Blood?: Fascinating Answers to Questions about Bats. Animal Q &amp; A: Fascinating Answers to Questions about Animals. By Barbara A.SchmidtFrench and, Carol A.Butler. New Brunswick (New Jersey): Rutgers University Press. $21.95 (paper). xiii 155 p. 8 pl.; ill.; index. 9780813545875 (hc); 9780813545882 (pb). 2009.

Previous articleNext article No AccessNew Biological BooksZoology Do Bats Drink Blood?: Fascinating Answers to Questions about Bats. Animal Q & A: Fascinating Answers to Questions about Animals. By Barbara A.SchmidtFrench and, Carol A.Butler. New Brunswick (New Jersey): Rutgers University Press. $21.95 (paper). xiii 155 p. 8 pl.; ill.; index. 9780813545875 (hc); 9780813545882 (pb). 2009.TheodoreH.FlemingTheodoreH.FlemingBiology, University of Miami, Coral Gables, Florida Search for more articles by this author Biology, University of Miami, Coral Gables, FloridaPDFPDF PLUSFull Text Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited by The Quarterly Review of Biology Volume 85, Number 2June 2010 Published in association with Stony Brook University Article DOIhttps://doi.org/10.1086/652358 Views: 16Total views on this site 2010 by The University of Chicago Press. All rights reserved.PDF download Crossref reports no articles citing this article.

Good Timing? How One Bank Cut Its Link to a $1.2 Billion Ponzi Scheme

On September 17, 2009, Boston Private Financial Holdings (BPFH) sold its Coral Gables, Florida based Gibraltar Private Bank & Trust subsidiary for $93 million. On October 27, 2009, Scott Rothstein fled to Morocco on a private jet before turning himself in to authorities. Mr. Rothstein has subsequently pled guilty to running a $1.2 billion Ponzi scheme with substantial deposits at Gibraltar Bank. Scott Rothstein had a 5 percent equity stake in the group that bought Gibraltar Bank from BPFH. Investors cheered the news of the sale producing a 27 percent one-day return after the Gibraltar Bank sale was released, adding over $100 million of market value overnight. Using a geometric Brownian motion model of the stock price, we find there was almost no chance that this was a random swing in the stock price. This sale, nevertheless, may not shield BPFH from legal liability from Mr. Rothstein’s four-year Ponzi scheme.

Letters to the Editors: Re: In Response to Dr. Vafaei

1. Bernard H. Cohen, MD 1. Coral Gables, Florida The system is a delicate balance of mathematics, anatomy, and historical precedent. When multiple zones are configured in combination, an established Norwood pattern is created. A precise proportionality exists between the anatomic surface area

Density and Natural Enemies of the Asian Citrus Psyllid, Diaphorina citri (Hemiptera: Psyllidae), in the Residential Landscape of Southern Florida

Abstract This study was conducted to determine the density, the incidence of parasitism, and the generalist predator assemblage of the Asian citrus psyllid, Diaphorina citri Kuwayama (Hemiptera: Psyllidae), on orange jasmine plants [Murraya paniculata (L.) Jack] in the residential landscape of Miami-Dade County, Florida. Flush shoots (10 cm) were collected from ten orange jasmine hedges in each of the four communities (Doral, Coral Gables, Palmetto Bay, and Homestead). We did not detect any consistent pattern in the fluctuation of psyllid density over time in the four communities. The greatest densities of eggs (65.5 ± 36.3 eggs/shoot), early instars (first to third) (87.2 ± 47.8 nymphs/shoot), and late instars (fourth and fifth) (16.9 ± 9.3 nymphs/shoot) were detected on 24 May 2006 in Palmetto Bay (egg) and Doral (early and late instars). The density of adult psyllids remained below two individuals per flush shoot at all locations for the entire sampling period. There were no consistent correlations bet...

Co-editors’ Messages

1. Bernard Nusbaum, MD 1. Coral Gables, Florida </br>![][1]</img> Techniques in our field are in constant evolution and, in this issue, we continue with our goal of rapid communication, by presenting further variations to the theme of trichophytic closure. Dr. Kazuhito Yamamoto’s study

The Cohen hair loss classification system

1. Bernard Cohen, MD (bcmd{at}mac.com) 1. Coral Gables, Florida In order to classify the stages of androgenetic alopecia, hair restoration surgeons use the 50-year-old Hamilton and Norwood (H-N) system that compares the patient’s hair loss pattern to a set of black and white drawings.[1][1

PHARMACEUTICALS GSK continues diversification drive with purchase of Stiefel

GlaxoSmithKline has agreed to acquire Stiefel Laboratories, a leading maker of dermatology drugs, for $2.9 billion plus $400 million in debt and a potential $300 million cash payment. Stiefel, a privately held firm based in Coral Gables, Fla., had sales last year of about $900 million. It mostly sells topical prescription products that treat acne, psoriasis, and other ailments of the skin. GSK CEO Andrew Witty says the purchase fits with his company’s strategy of growth and diversification. GSK already has prescription dermatology drug sales of about $550 million per year. It will combine the two operations into a new business that will operate under the Stiefel name. GSK is one of several big pharmaceutical makers that are trying to diversify to move away from the boom-and-bust cycle of blockbuster drugs and into more stable businesses, such as generics and drugs for the developing world. In January, for example, the firm spent close to $700 ...

Review of the Clinical Debate Regarding Interventions for Multiple Sclerosis

BACKGROUND: Multiple sclerosis (MS) is a debilitating and progressive neurologic disorder characterized by relapses and neurological deterioration. The mainstay of treatment for MS are the disease-modifying therapies (DMTs), which are costly biologic agents designed to reduce the rate of relapse and progression of the disease. Despite the presence of several approved medications and a substantial amount of experience with these agents, various uncertainties remain regarding the optimal management of MS. Issues that are frequently debated include when to start therapy, which agent to use, how to improve adherence to DMT, and issues related to long-term use of DMTs. OBJECTIVE: To familiarize managed health care professionals with current issues and ongoing challenges in the management of MS, and to consider potential strategies to overcome these challenges and optimize treatment outcomes. SUMMARY: Despite the existence of effective therapies for MS, clinical debate exists regarding the optimal management of patients with this disease. While there are few clear answers to the questions posed by current issues in MS management, with careful consideration and investigation of existing medical evidence, the best course of action for the patient with MS can be estimated and hopefully refined in years to come. J Manag Care Pharm. 2009;15(1)(Suppl S-b):S1-S17 Copyright © 2009, Academy of Managed Care Pharmacy. All rights reserved. MELODY RYAN, PharmD, MPH, GCP, BCPS, is Associate Professor, Department of Pharmacy Practice and Science and Department of Neurology, University of Kentucky Chandler Medical Center, Lexington, Kentucky. AUTHOR CORRESPONDENCE: Melody Ryan, PharmD, MPH, Associate Professor, University of Kentucky Chandler Medical Center, 800 Rose Street, Room C117, Lexington, KY 40536-0293. Tel: 859.257.8790; Fax: 859.323.0069; E-mail: maryan1@pop.uky.edu SARA DENO, PharmD, is Clinical Services Manager, BioScrip, Eden Prairie, Minnesota. AUTHOR CORRESPONDENCE: Sara Deno, PharmD, Clinical Services Manager, BioScrip, Inc., 10050 Crosstown Circle, Suite 300, Eden Prairie, Minnesota, 55344. Tel: 952.979.3690; Fax: 952.352.6663; E-mail: sdeno@bioscrip.com HOWARD L. ZWIBEL, MD, is Medical Director, The Multiple Sclerosis Center at Doctors Hospital, Coral Gables, Florida. AUTHOR CORRESPONDENCE: Howard Zwibel, MD, Medical Director, The Multiple Sclerosis Center at Doctors Hospital, 6862 Granada Boulevard, Coral Gables, Florida 33146. Tel: 305.665.2344; Fax: 305.662.8775; E-mail: zwibelmdms@aol.com Authors

Co-editors’ Messages

1. Bernard Nusbaum, MD 1. Coral Gables, Florida </br>![][1]</img> The central theme of this issue is the Montréal Annual Meeting and, as always, you will find a detailed report of the lectures, panel discussions, and poster presentations. The meeting was full of new ideas for presenting

Drastically Decreased Reactivity of Thiols and Disulfides Complexed by Cucurbit[6]uril

The cucurbit[6]uril (CB6) host forms stable complexes with 2-aminoethanethiol (cysteamine) and a derivative that contains a bulky terminal group attached to the amine group, as well as with the related disulfide cystamine. In these complexes, the thiol or the disulfide group is encapsulated inside the host cavity. The CB6-complexed thiols show drastically decreased reactivity with several oxidants, while the CB6-bound disulfide also exhibits hindered reactivity with reducing agents, such as dithiothreitol.

Subsplenic ectopic pregnancy adjacent to a rudimentary uterine horn

a Nova Southeastern University College of Osteopathic Medicine, Fort Lauderdale, FL, USA b Department of Obstetrics and Gynecology, College of Medicine, Florida International University, FL, USA c Department of Public Health, College of Health Sciences, Walden University, Baltimore, MD, USA d Department of Epidemiology and Public Health, Miller School of Medicine, University of Miami, Miami, FL, USA e South Florida Gynecologic Oncology, Doctors Hospital, Coral Gables, FL, USA

Hair breakage: an under appreciated cause of hair loss in women

1. Bernard Cohen, MD 1. Coral Gables, Florida Editor’s note: Dr. Cohen will introduce his trichometer device in the scientific literature in a comprehensive 11-page article that will appear in Dermatologic Surgery in July 2008. By measuring changes in the hair quantity (hair mass), hair

Travel Awards for Graduate Students Attending 2001 Annual Meeting

Next article FreeTravel Awards for Graduate Students Attending 2001 Annual MeetingPDFPDF PLUSFull Text Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinked InRedditEmailQR Code SectionsMoreTravel Awards for Graduate Students Attending the 2008 Annual MeetingThe American Society of Naturalists will award $300 each to ten graduate students to help defray the cost of attending the 2008 annual meeting at the University of Minnesota, Minneapolis. Awards will be chosen from a random drawing of eligible students who have submitted an application before April 1, 2008. To be eligible, you must be a student member of the American Society of Naturalists, and you must not have received a travel award the previous year. You must also be presenting a paper or a poster at the meeting. Awardees will be contacted by April 15, 2008.You can download PDF or PostScript of the entry form from the menu on this page. Please submit completed form to Dr. Carol C. Horvitz, Department of Biology, University of Miami, P.O. Box 249118, Coral Gables, Florida 33124; email: [email protected]. Next article DetailsFiguresReferencesCited by The American Naturalist Volume 171, Number 4April 2008 Published for The American Society of Naturalists Article DOIhttps://doi.org/10.1086/587769 Views: 130Total views on this site PDF download Crossref reports no articles citing this article.

Hyaluronic acid gel fillers in the management of facial aging

Hyaluronic acid gel fillers in the management of facial aging Fredric S Brandt1, Alex Cazzaniga21Private Practice in Coral Gables, Florida, USA and Manhattan, NY, USA, and Dermatology Research Institute, Coral Gables, FL, USA; 2Dermatology Research Institute, Coral Gables, Florida, USAAbstract: Time affects facial aging by producing cellular and anatomical changes resulting in the consequential loss of soft tissue volume. With the advent of new technologies, the physician has the opportunity of addressing these changes with the utilization of dermal fillers. Hyaluronic acid (HA) dermal fillers are the most popular, non-permanent injectable materials available to physicians today for the correction of soft tissue defects of the face. This material provides an effective, non invasive, non surgical alternative for correction of the contour defects of the face due to its enormous ability to bind water and easiness of implantation. HA dermal fillers are safe and effective. The baby-boomer generation, and their desire of turning back the clock while enjoying an active lifestyle, has expanded the popularity of these fillers. In the US, there are currently eight HA dermal fillers approved for commercialization by the Food and Drug Administration (FDA). This article reviews the innate properties of FDA-approved HA fillers and provides an insight on future HA products and their utilization for the management of the aging face.Keywords: hyaluronic acid, aging face, dermal filler, wrinkles, Restylane, Perlane, Juvéderm

From Departing Editor

From Departing Editor Bruce Boehrer Since this issue of JEMCS marks the end of my service to the journal, my co-editors have kindly allowed me to compose a final introductory column in propria persona. The five essays appearing in JEMCS 8.1 represent three recurring areas of interest for the journal’s contributors and its parent Group: the history of cross-cultural exchange, the articulation of gender, and the growth of the modern scientific imaginary. Carmen Nocentelli’s “The Erotics of Mercantile Imperialism” and Lucas Marchante-Aragón’s “The King, the Nation, and the Moor” represent the first of these general topics, which they approach from different geographical angles. Nocentelli explores the dynamics of early European trade and diplomacy primarily in East Asia, whereas Marchante-Aragón engages Europe’s long and troubled history with the Islamic Middle East and North Africa. In both cases, what emerges is a complicated legacy of interdependence, such that the European self seeks to distinguish itself from racial and cultural others that nonetheless reemerge as objects of desire and fascination in the discourse of European supremacy. In examining the notion of cross-cultural desire, both Nocentelli and Marchante-Aragón nudge their work in the direction of gender studies. Two other essays in this issue of JEMCS address questions of gender more squarely. In “‘Rich Like a Lady’: Cross-Class Dressing in the Brothels and Theaters of Early Modern London,” Cristine Varholy seizes upon a common preoccupation of recent scholarship on the early modern English theater—cross-dressing. But she studies this subject from the standpoint of class rather than gender, in the process shedding light upon a whole vocabulary of theatrical and non-theatrical desire keyed to expressions of social privilege. For her part, Amy Greenstadt reads Aemilia Lanyer’s “Description of Cooke-ham” as an allegory [End Page 1] of femme-femme desire, relayed across the boundaries of rank and imprinted upon the landscape of the Countess of Cumberland’s country residence. Finally, in “Ben Jonson’s Alchemist and Early Modern Laboratory Space,” John Shanahan presents Jonson’s great comedy as a literary anticipation of the experimental method, as this was envisioned by Bacon and developed by the Royal Society. For Shanahan, The Alchemist proceeds by the limitation and manipulation of variables, particularly time and space, thus creating an artificial space for the production of truths that may then be taken as representative of the broader world beyond the theater itself. In this respect, we may see Jonsonian neoclassicism as implicated in the development of early modern proto-scientific theory and procedures. These fine articles comprise the current issue of JEMCS. But since this issue marks the end of my service on the JEMCS editorial board, it is perhaps also appropriate to offer a brief appraisal of the journal’s development over the past eight-and-a-half years. My earliest involvement with JEMCS—and with The Group for Early Modern Cultural Studies—came with my appearance at the Group’s 1999 meeting in Coral Gables, Florida. At that year’s business meeting, GEMCS agreed to pursue the possibility of establishing an affiliated journal, and so, after gaining some early financial assistance from the Florida State University Department of English, the JEMCS editorial board (then consisting of Laura J. Rosenthal, Daniel Vitkus, Helen Burke, and me) sent out our first call for papers and advertisement for the new journal in February 2000. Over the next twelve months we read submissions, assembled a preliminary backlog, and prepared the first issue of the journal, which appeared in late spring 2001. For three-and-a-half years thereafter, JEMCS developed as a semi-annual self-published project housed primarily within the FSU English Department. By late 2004, however, some members of the Group for Early Modern Cultural Studies had begun calling for the journal to affiliate itself with a university press, in order to enhance its visibility and distribution network. In response to these calls, the journal signed an initial publishing contract with Indiana University Press, with the result that JEMCS started appearing in a redesigned format in Fall/Winter 2004, under the umbrella of the IUP Journals Division. Last year, JEMCS renewed...

Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis

Two advanced formulations of clobetasol propionate (CP) 0.05% (Clobex® Spray; Galderma Laboratories, L.P., Fort Worth, TX, USA and Olux® Foam; Stiefel/Connetics Corp., Coral Gables, FL, USA) were compared in a study of 77 randomized patients with moderate to severe plaque psoriasis. At the end of the treatment period (2 weeks for CP foam or up to 4 weeks for CP spray per product labeling), patients treated with CP spray had a median 64% reduction in affected body surface area (BSA) compared to a median 25% reduction in patients treated with the CP foam (p = 0.004). Also at the end of the treatment period, 22% of CP spray‐treated patients were completely clear compared to 5% of CP foam‐treated patients (p = 0.04). Improvements in quality of life as determined by the Dermatology Life Quality Index were statistically significantly greater at all time points for patients treated with CP spray compared to patients treated with CP foam (p<0.04 for all). The majority of adverse events for both products were mild in severity. Thus, while both of these formulations contain the same active ingredient at the same concentration, differences in their efficacy were observed when each treatment was used within its approved labeling guidelines.